Drugmaker Bristol-Myers Squibb said Monday it will work with Dutch biotechnology company uniQure to develop gene therapies for cardiovascular diseases.
The companies will focus first on a treatment for congestive heart failure. They said uniQure could get more than $2.2 billion from the deal in total, and Bristol-Myers Squibb will also take a minority stake in the company.
13:37 GoPro to cut about 15 percent of workforce13
00:27 Trump warns of ‘retribution’ if companies move jobs out of U.S10
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff13
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle14